牛牛AI助理已提取核心訊息
On February 1, 2024, Timothy K Lu, CEO and President of Senti Biosciences, Inc. (SNTI), completed a significant stock transaction involving the company's common stock. Lu was granted 306,000 shares at no cost, as per the transaction details. Following this grant, Lu's direct holdings in Senti Biosciences increased to a total of 865,496 shares. Additionally, Lu has indirect beneficial ownership of 1,056,780 shares, which includes shares held by his spouse and others as detailed in the footnotes. The transaction reflects a substantial increase in Lu's stake in the company, emphasizing his vested interest in the company's success.
On February 1, 2024, Timothy K Lu, CEO and President of Senti Biosciences, Inc. (SNTI), completed a significant stock transaction involving the company's common stock. Lu was granted 306,000 shares at no cost, as per the transaction details. Following this grant, Lu's direct holdings in Senti Biosciences increased to a total of 865,496 shares. Additionally, Lu has indirect beneficial ownership of 1,056,780 shares, which includes shares held by his spouse and others as detailed in the footnotes. The transaction reflects a substantial increase in Lu's stake in the company, emphasizing his vested interest in the company's success.
2024年2月1日，森蒂生物科學公司（SNTI）首席執行官兼總裁盧****完成了一項涉及該公司普通股的重大股票交易。根據交易細節，盧無償獲得了30.6萬股股票。在這筆贈款之後，盧在森蒂生物科學的直接持股量增加到總計865,496股。此外，盧擁有1,056,780股股票的間接實益所有權，其中包括其配偶和其他人持有的股份，詳見腳註。該交易反映了盧在公司的股份大幅增加，凸顯了他在公司成功中的既得利益。
2024年2月1日，森蒂生物科學公司（SNTI）首席執行官兼總裁盧****完成了一項涉及該公司普通股的重大股票交易。根據交易細節，盧無償獲得了30.6萬股股票。在這筆贈款之後，盧在森蒂生物科學的直接持股量增加到總計865,496股。此外，盧擁有1,056,780股股票的間接實益所有權，其中包括其配偶和其他人持有的股份，詳見腳註。該交易反映了盧在公司的股份大幅增加，凸顯了他在公司成功中的既得利益。
有用
沒用
該公告為獨立文件：